TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Swedish Orphan Biovitrum AB (publ)
Closing information (x1000 EUR)
| Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Turnover |
1,365,588
|
889,404
|
661,018 |
| Financial expenses |
27,891
|
5,806
|
7,022 |
| Earnings before taxes |
407,050
|
299,917
|
155,581 |
| Total assets |
4,376,054
|
1,672,278
|
1,106,928 |
| Current assets |
701,867
|
642,503
|
422,050 |
| Current liabilities |
550,242
|
676,483
|
240,090 |
| Equity capital |
1,622,642
|
879,789
|
680,277 |
| - share capital |
15,814
|
14,552
|
15,181 |
| Employees (average) |
1,335
|
902
|
800 |
Financial ratios
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Solvency |
37.1%
|
52.6%
|
61.5% |
| Turnover per employee |
1,023
|
986
|
826 |
| Profit as a percentage of turnover |
29.8%
|
33.7%
|
23.5% |
| Return on assets (ROA) |
9.9%
|
18.3%
|
14.7% |
| Current ratio |
127.6%
|
95.0%
|
175.8% |
| Return on equity (ROE) |
25.1%
|
34.1%
|
22.9% |
| Change turnover |
489,678
|
255,765
|
132,643 |
| Change turnover % |
56%
|
40%
|
25% |
| Chg. No. of employees |
433
|
102
|
40 |
| Chg. No. of employees % |
48%
|
13%
|
5% |
Total value of public sale
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.